Profil
Daniel Cohen is the founder of Pharnext SA, which was founded in 2007.
He held the title of Chairman from 2010 to 2012.
Mr. Cohen is also the founder of Millennium Pharmaceuticals, Inc., Fondation Jean Dausset-CEPH, Genethon.
In addition to his founding positions, Mr. Cohen held former positions as Vice President-Worldwide Genetics at Serono Genetics Institute SA, Chief Scientific Officer at Genset Corp., and Global Vice President-Genetics at Serono Ltd.
Ehemalige bekannte Positionen von Daniel Cohen
| Unternehmen | Position | Ende |
|---|---|---|
| PHARNEXT SCA | Chief Executive Officer | 16.04.2020 |
| Fondation Jean Dausset-CEPH | Founder | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Founder | - |
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Founder | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The private company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Genset Corp.
 Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The private company is based in San Diego, CA and is a part of Merck KGaA. | Health Technology |
| Serono Ltd. | |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
| Fondation Jean Dausset-CEPH |
